Mechanistically, CapG binds to chromatin and enhances transcription of PIK3R1. The upregulation of PIK3R1, especially its p50α isoform, substantially augments the activation of PI3K/Akt pathway, resulting in increased cell proliferation and decreased apoptosis in breast cancer cells upon paclitaxel treatment. Here, CAPG is linked to breast carcinoma.